1 / 32

Bronchiolitis Obliterans Organising Pneumonia (BOOP), G ranulomatosis with Polyangiitis

Bronchiolitis Obliterans Organising Pneumonia (BOOP), G ranulomatosis with Polyangiitis. פרופ' נוויל ברקמן מכון הריאה ביה"ח האוניברסיטאי הדסה עין-כרם. Brochiolitis Obliterans and Organising Pneumonia (BOOP). Clinico- Pathological Diagnosis Clinical Radiological Pathological.

kelda
Télécharger la présentation

Bronchiolitis Obliterans Organising Pneumonia (BOOP), G ranulomatosis with Polyangiitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Bronchiolitis Obliterans Organising Pneumonia (BOOP), Granulomatosis with Polyangiitis פרופ' נוויל ברקמןמכון הריאהביה"ח האוניברסיטאי הדסה עין-כרם

  2. Brochiolitis Obliterans and Organising Pneumonia (BOOP) • Clinico- Pathological Diagnosis • Clinical • Radiological • Pathological

  3. Brochiolitis Obliterans and Organising Pneumonia (BOOP)Differential Diagnosis • Idiopathic (Cryptogenic Organising Pneumonia) • Infection • Post-transplantation • Collagen vascular disease • Irradiation • Drugs • Other

  4. Idiopathic BOOP (Cryptogenic Organising Pneumonia) • M=F, any age (mean 58). • Acute or subacute onset of cough, fever, fatigue, weight loss, dyspnea "slowly or non-resolving pneumonia" • Inspiratory crackles, leukocytosis, raised ESR • X-ray: Bilateral diffuse alveolar infiltrates, peripheral, nodular, lower lobes, pleural effusion is rare.

  5. COP- cont. • PFTs: restriction, reduced diffusion, obstruction (20%), hypoxemia. • Diagnosis: characteristic pathology with fibrotic buds in alveoli (organising pneumonia) and bronchiolitis obliterans. • Treatment: Steroids, cyclophosphamide. • 2/3 respond, others have progressive disease.

  6. Pulmonary Vasculitis • Granulomatous vasculitis syndromes • Granulomatosis with polyangiitis (GPA) Wegener's vasculitis • Eosinophilic Granulomatosis with polyangiitis (EGPA) Churg-Strauss vasculitis • Lymphomatoid granulomatosis • Pulmonary-renal syndromes • Microscopic polyangiitis (overlap polyangiitis syndrome) • pauci-immune glomerulonephritis • Classical polyarteritis nodosa • Giant cell arteritis • Takayasu's disease • Behcet's disease

  7. Granulomatosis with polyangiitis (GPA)Definition • A multi-organ disease histologically characterized by necrotizing vasculitis involving the small vessels, extensive necrosis & granulomatous inflammation

  8. Granulomatosis with polyangiitisClinical manifestations Hoffman GS: Ann Intern Med 1992;116:488

  9. Granulomatosis with polyangiitis

  10. Antineutrophil Cytoplasmic Antibodies (ANCA)

  11. Granulomatosis with polyangiitisPathology • Necrotizing vasculitis: arterioles, venules & capillaries • Granulomatous inflammation • Geographical parenchymal necrosis • Hemorrhagic infarcts • Fibrosis

  12. Granulomatosis with polyangiitisTreatment • Mortality >80% within 3 years without adequate treatment • Treatment of choice: • Prednisone 1mg/kg/day • Cyclophosphamide 1-2mg/kg/day (orally) • Remission is achieved in 70-93%

  13. Eosinophilic granulomatosis with polyangiitisChurg-Strauss syndrome • History of asthma • Marked blood eosinophilia (up to 10000/ul) • Vasculitis, eosinophilic tissue infiltration • Sinusits • Skin (70%)- nodules,purpura, urticaria • Nervous system- mononeuritis muliplex (66%), CNS • GIT- abdominal pain (60%), diarrhea (33%), bleeding • Cardiac- cardiac failure (50%), pericarditis, hypertension • Renal- dysfunction (50%) • fever, lymphadenopathy

  14. Churg-Strauss cont. • Lungs- infiltrates (>70%), usually transient and patchy, also nodules , interstitial infiltrates, pleural effusion (1/3). • Obstructive PFTs, elevated IgE, anemia, elevated ESR • BAL- eosinophilia (33%), eosinophils in pleural fluid • Biopsy- necrotising giant cell vasculitis (small arteries and veins), eosinophils, granulomas. • Treatment: Steroids, cyclophosphamide.

  15. Rheumatoid ArthritisPulmonary manifestations • Pleural disease pleurisy (20%), effusion (4%), unilateral (80%), R>L middle-aged male, any time during the illness Associated with nodules not arthritis Fluid: exudate, LDH>1000, low glucose (<50mg% in 80%),low pH, lymphocytic, RF +, low complement

  16. RA-cont. • Interstitial pneumonitis identical to idiopathic pulmonary fibrosis fullblown in 2%, abnormal PFTs in 41% M>F, patients are RF positive Cough, dyspnea, dry rales, clubbing hypoxemia, restrictive PFTs, reduced DCO Variable response to steroids Poor prognosis (survival 3-5 years) May be drug-induced (methotrexate, gold, penicillamine)

  17. RA-cont. • Nodules: single (1/3) or multiple (2/3), more common in men related to disease activity and skin nodules asymptomatic, may cavitate, rarely hemoptysis peripheral, 0.3-7cm diameter may respond to steroids • Caplan's syndrome: pulmonary nodules with RA in coal miners (coal miner's pneumoconiosis)

  18. RA-cont. • Bronchiolitis Obliterans airways obstruction, 60% of smokers, 30% of non-smokers peribronchial inflammatory infiltrate may be drug-induced • Pulmonary hypertension pulmonary arteritis

  19. Systemic Lupus ErythematosisPulmonary manifestations • Pleura:- pleuritis or effusion, 50-75% of patients, presenting symptom in 1/3, fluid is an exudate, PMNs, raised ANF, LE cells • Interstitial pneumonitis:- acute (fever,cough, progressive hypoxemia) or chronic • Pulmonary thromboembolic disease:- lupus anticoagulant positive patients • Diaphragmatic dysfunction • Atalectasis:- subsegmental, bibasilar • INFECTION!

  20. Goodpasture's syndrome • Alveolar hemorrhage • Glomerulonephritis • Anti-glomerular basement membrane antibody

  21. Goodpasture's syndrome • Young males • Autoimmune disorder • Clinical features: Rapidly-progressive glomerulonephritis Hematuria, proteinuria, renal failure Hemoptysis, dyspnea, cough Anemia Arthralgia

  22. Goodpasture's syndrome • Laboratory features: X-ray: transient infiltrates Urine:red cells, casts Iron-deficiency anemia Restrictive defect on lung-function tests with increased diffusion capacity. • Diagnosis: Hemosiderin-laden macrophages Anti-GBM antibodies Renal biopsy • Treatment: Plasmapharesis, steroids, cyclophosphamide.

More Related